When managing a patient on oral albuterol for asthma, which adverse effect should the nurse monitor for?

Monitoring for tachycardia is essential when a patient is taking oral albuterol for asthma management. Albuterol is a beta-2 adrenergic agonist that primarily acts on the bronchial smooth muscle to cause bronchodilation. However, it can also stimulate beta-1 adrenergic receptors in the heart, which can lead to increased heart rate.

Patients may experience an increase in heart rate and palpitations as a common adverse effect, particularly with higher doses or in sensitive individuals. Since tachycardia can exacerbate pre-existing heart conditions or cause discomfort, it is crucial for the nurse to assess the patient's heart rate regularly and educate them about this potential side effect. Additionally, if a patient experiences significant tachycardia, it may require adjustment of the medication or further evaluation of the patient's asthma management plan to ensure safety and efficacy.